Figure 4.
Twenty-four hour fluctuation for oral bioavailability (F) and clearance (CL) according to the final model with the 95% confidence interval of the empirical Bayes estimates (EBEs) for F (IIV+IOV) and CL (IIV) at each administration time. For oral bioavailability, the time of the peak was estimated at 12:14 with an estimated amplitude of 0.041 (14.7% increase) (upper panel). For clearance, the time of the peak was estimated at 18:50 with an estimated amplitude of 0.027 L/min (7.2% increase) (lower panel).